Pre-order Enquiry
Request Free Sample
Global Non-small Cell Lung Cancer Therapeutics Market Size, Status and Forecast 2021-2027
SKU ID : QYR-17247035 | Publishing Date : 22-Jan-2021 | No. of pages : 97
Detailed TOC of Global Non-small Cell Lung Cancer Therapeutics Market Size, Status and Forecast 2021-2027
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non-small Cell Lung Cancer Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Alimta
1.2.3 Iressa
1.2.4 Avastin
1.2.5 Tarceva
1.2.6 Zykadia
1.2.7 Tagrisso
1.2.8 Xalkori
1.2.9 Cyramza
1.2.10 Opdivo
1.2.11 Alecensa
1.3 Market by Application
1.3.1 Global Non-small Cell Lung Cancer Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Non-small Cell Lung Cancer Therapeutics Market Perspective (2016-2027)
2.2 Non-small Cell Lung Cancer Therapeutics Growth Trends by Regions
2.2.1 Non-small Cell Lung Cancer Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Non-small Cell Lung Cancer Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Non-small Cell Lung Cancer Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Non-small Cell Lung Cancer Therapeutics Industry Dynamic
2.3.1 Non-small Cell Lung Cancer Therapeutics Market Trends
2.3.2 Non-small Cell Lung Cancer Therapeutics Market Drivers
2.3.3 Non-small Cell Lung Cancer Therapeutics Market Challenges
2.3.4 Non-small Cell Lung Cancer Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Non-small Cell Lung Cancer Therapeutics Players by Revenue
3.1.1 Global Top Non-small Cell Lung Cancer Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Non-small Cell Lung Cancer Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Non-small Cell Lung Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Non-small Cell Lung Cancer Therapeutics Revenue
3.4 Global Non-small Cell Lung Cancer Therapeutics Market Concentration Ratio
3.4.1 Global Non-small Cell Lung Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non-small Cell Lung Cancer Therapeutics Revenue in 2020
3.5 Non-small Cell Lung Cancer Therapeutics Key Players Head office and Area Served
3.6 Key Players Non-small Cell Lung Cancer Therapeutics Product Solution and Service
3.7 Date of Enter into Non-small Cell Lung Cancer Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Non-small Cell Lung Cancer Therapeutics Breakdown Data by Type
4.1 Global Non-small Cell Lung Cancer Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Non-small Cell Lung Cancer Therapeutics Forecasted Market Size by Type (2022-2027)
5 Non-small Cell Lung Cancer Therapeutics Breakdown Data by Application
5.1 Global Non-small Cell Lung Cancer Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Non-small Cell Lung Cancer Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Non-small Cell Lung Cancer Therapeutics Market Size (2016-2027)
6.2 North America Non-small Cell Lung Cancer Therapeutics Market Size by Type
6.2.1 North America Non-small Cell Lung Cancer Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Non-small Cell Lung Cancer Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Non-small Cell Lung Cancer Therapeutics Market Size by Type (2016-2027)
6.3 North America Non-small Cell Lung Cancer Therapeutics Market Size by Application
6.3.1 North America Non-small Cell Lung Cancer Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Non-small Cell Lung Cancer Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Non-small Cell Lung Cancer Therapeutics Market Size by Application (2016-2027)
6.4 North America Non-small Cell Lung Cancer Therapeutics Market Size by Country
6.4.1 North America Non-small Cell Lung Cancer Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Non-small Cell Lung Cancer Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Non-small Cell Lung Cancer Therapeutics Market Size (2016-2027)
7.2 Europe Non-small Cell Lung Cancer Therapeutics Market Size by Type
7.2.1 Europe Non-small Cell Lung Cancer Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Non-small Cell Lung Cancer Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Non-small Cell Lung Cancer Therapeutics Market Size by Type (2016-2027)
7.3 Europe Non-small Cell Lung Cancer Therapeutics Market Size by Application
7.3.1 Europe Non-small Cell Lung Cancer Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Non-small Cell Lung Cancer Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Non-small Cell Lung Cancer Therapeutics Market Size by Application (2016-2027)
7.4 Europe Non-small Cell Lung Cancer Therapeutics Market Size by Country
7.4.1 Europe Non-small Cell Lung Cancer Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Non-small Cell Lung Cancer Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Non-small Cell Lung Cancer Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Non-small Cell Lung Cancer Therapeutics Market Size by Type
8.2.1 Asia-Pacific Non-small Cell Lung Cancer Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Non-small Cell Lung Cancer Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Non-small Cell Lung Cancer Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Non-small Cell Lung Cancer Therapeutics Market Size by Application
8.3.1 Asia-Pacific Non-small Cell Lung Cancer Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Non-small Cell Lung Cancer Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Non-small Cell Lung Cancer Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Non-small Cell Lung Cancer Therapeutics Market Size by Region
8.4.1 Asia-Pacific Non-small Cell Lung Cancer Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Non-small Cell Lung Cancer Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Non-small Cell Lung Cancer Therapeutics Market Size (2016-2027)
9.2 Latin America Non-small Cell Lung Cancer Therapeutics Market Size by Type
9.2.1 Latin America Non-small Cell Lung Cancer Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Non-small Cell Lung Cancer Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Non-small Cell Lung Cancer Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Non-small Cell Lung Cancer Therapeutics Market Size by Application
9.3.1 Latin America Non-small Cell Lung Cancer Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Non-small Cell Lung Cancer Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Non-small Cell Lung Cancer Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Non-small Cell Lung Cancer Therapeutics Market Size by Country
9.4.1 Latin America Non-small Cell Lung Cancer Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Non-small Cell Lung Cancer Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Non-small Cell Lung Cancer Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Non-small Cell Lung Cancer Therapeutics Market Size by Type
10.2.1 Middle East & Africa Non-small Cell Lung Cancer Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Non-small Cell Lung Cancer Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Non-small Cell Lung Cancer Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Non-small Cell Lung Cancer Therapeutics Market Size by Application
10.3.1 Middle East & Africa Non-small Cell Lung Cancer Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Non-small Cell Lung Cancer Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Non-small Cell Lung Cancer Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Non-small Cell Lung Cancer Therapeutics Market Size by Country
10.4.1 Middle East & Africa Non-small Cell Lung Cancer Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Non-small Cell Lung Cancer Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Non-small Cell Lung Cancer Therapeutics Introduction
11.1.4 GlaxoSmithKline Revenue in Non-small Cell Lung Cancer Therapeutics Business (2016-2021)
11.1.5 GlaxoSmithKline Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Non-small Cell Lung Cancer Therapeutics Introduction
11.2.4 Novartis Revenue in Non-small Cell Lung Cancer Therapeutics Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Details
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Non-small Cell Lung Cancer Therapeutics Introduction
11.3.4 AstraZeneca Revenue in Non-small Cell Lung Cancer Therapeutics Business (2016-2021)
11.3.5 AstraZeneca Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Non-small Cell Lung Cancer Therapeutics Introduction
11.4.4 Roche Revenue in Non-small Cell Lung Cancer Therapeutics Business (2016-2021)
11.4.5 Roche Recent Development
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Details
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb Non-small Cell Lung Cancer Therapeutics Introduction
11.5.4 Bristol-Myers Squibb Revenue in Non-small Cell Lung Cancer Therapeutics Business (2016-2021)
11.5.5 Bristol-Myers Squibb Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Non-small Cell Lung Cancer Therapeutics Introduction
11.6.4 Pfizer Revenue in Non-small Cell Lung Cancer Therapeutics Business (2016-2021)
11.6.5 Pfizer Recent Development
11.7 Eli Lilly
11.7.1 Eli Lilly Company Details
11.7.2 Eli Lilly Business Overview
11.7.3 Eli Lilly Non-small Cell Lung Cancer Therapeutics Introduction
11.7.4 Eli Lilly Revenue in Non-small Cell Lung Cancer Therapeutics Business (2016-2021)
11.7.5 Eli Lilly Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Non-small Cell Lung Cancer Therapeutics Introduction
11.8.4 Sanofi Revenue in Non-small Cell Lung Cancer Therapeutics Business (2016-2021)
11.8.5 Sanofi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global Non-small Cell Lung Cancer Therapeutics Market Size, Status and Forecast 2021-2027
List of TablesTable 1. Global Non-small Cell Lung Cancer Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Alimta
Table 3. Key Players of Iressa
Table 4. Key Players of Avastin
Table 5. Key Players of Tarceva
Table 6. Key Players of Zykadia
Table 7. Key Players of Tagrisso
Table 8. Key Players of Xalkori
Table 9. Key Players of Cyramza
Table 10. Key Players of Opdivo
Table 11. Key Players of Alecensa
Table 12. Global Non-small Cell Lung Cancer Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 13. Global Non-small Cell Lung Cancer Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 14. Global Non-small Cell Lung Cancer Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 15. Global Non-small Cell Lung Cancer Therapeutics Market Share by Regions (2016-2021)
Table 16. Global Non-small Cell Lung Cancer Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 17. Global Non-small Cell Lung Cancer Therapeutics Market Share by Regions (2022-2027)
Table 18. Non-small Cell Lung Cancer Therapeutics Market Trends
Table 19. Non-small Cell Lung Cancer Therapeutics Market Drivers
Table 20. Non-small Cell Lung Cancer Therapeutics Market Challenges
Table 21. Non-small Cell Lung Cancer Therapeutics Market Restraints
Table 22. Global Non-small Cell Lung Cancer Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 23. Global Non-small Cell Lung Cancer Therapeutics Market Share by Players (2016-2021)
Table 24. Global Top Non-small Cell Lung Cancer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-small Cell Lung Cancer Therapeutics as of 2020)
Table 25. Ranking of Global Top Non-small Cell Lung Cancer Therapeutics Companies by Revenue (US$ Million) in 2020
Table 26. Global 5 Largest Players Market Share by Non-small Cell Lung Cancer Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Non-small Cell Lung Cancer Therapeutics Product Solution and Service
Table 29. Date of Enter into Non-small Cell Lung Cancer Therapeutics Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Non-small Cell Lung Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 32. Global Non-small Cell Lung Cancer Therapeutics Revenue Market Share by Type (2016-2021)
Table 33. Global Non-small Cell Lung Cancer Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 34. Global Non-small Cell Lung Cancer Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 35. Global Non-small Cell Lung Cancer Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 36. Global Non-small Cell Lung Cancer Therapeutics Revenue Market Share by Application (2016-2021)
Table 37. Global Non-small Cell Lung Cancer Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 38. Global Non-small Cell Lung Cancer Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 39. North America Non-small Cell Lung Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 40. North America Non-small Cell Lung Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 41. North America Non-small Cell Lung Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 42. North America Non-small Cell Lung Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 43. North America Non-small Cell Lung Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 44. North America Non-small Cell Lung Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Europe Non-small Cell Lung Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 46. Europe Non-small Cell Lung Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Europe Non-small Cell Lung Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 48. Europe Non-small Cell Lung Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Europe Non-small Cell Lung Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 50. Europe Non-small Cell Lung Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Non-small Cell Lung Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 52. Asia-Pacific Non-small Cell Lung Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Asia-Pacific Non-small Cell Lung Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 54. Asia-Pacific Non-small Cell Lung Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Asia-Pacific Non-small Cell Lung Cancer Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 56. Asia-Pacific Non-small Cell Lung Cancer Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 57. Latin America Non-small Cell Lung Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 58. Latin America Non-small Cell Lung Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Latin America Non-small Cell Lung Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 60. Latin America Non-small Cell Lung Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Latin America Non-small Cell Lung Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Latin America Non-small Cell Lung Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Non-small Cell Lung Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 64. Middle East & Africa Non-small Cell Lung Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 65. Middle East & Africa Non-small Cell Lung Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 66. Middle East & Africa Non-small Cell Lung Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 67. Middle East & Africa Non-small Cell Lung Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 68. Middle East & Africa Non-small Cell Lung Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 69. GlaxoSmithKline Company Details
Table 70. GlaxoSmithKline Business Overview
Table 71. GlaxoSmithKline Non-small Cell Lung Cancer Therapeutics Product
Table 72. GlaxoSmithKline Revenue in Non-small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 73. GlaxoSmithKline Recent Development
Table 74. Novartis Company Details
Table 75. Novartis Business Overview
Table 76. Novartis Non-small Cell Lung Cancer Therapeutics Product
Table 77. Novartis Revenue in Non-small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 78. Novartis Recent Development
Table 79. AstraZeneca Company Details
Table 80. AstraZeneca Business Overview
Table 81. AstraZeneca Non-small Cell Lung Cancer Therapeutics Product
Table 82. AstraZeneca Revenue in Non-small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 83. AstraZeneca Recent Development
Table 84. Roche Company Details
Table 85. Roche Business Overview
Table 86. Roche Non-small Cell Lung Cancer Therapeutics Product
Table 87. Roche Revenue in Non-small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 88. Roche Recent Development
Table 89. Bristol-Myers Squibb Company Details
Table 90. Bristol-Myers Squibb Business Overview
Table 91. Bristol-Myers Squibb Non-small Cell Lung Cancer Therapeutics Product
Table 92. Bristol-Myers Squibb Revenue in Non-small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 93. Bristol-Myers Squibb Recent Development
Table 94. Pfizer Company Details
Table 95. Pfizer Business Overview
Table 96. Pfizer Non-small Cell Lung Cancer Therapeutics Product
Table 97. Pfizer Revenue in Non-small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 98. Pfizer Recent Development
Table 99. Eli Lilly Company Details
Table 100. Eli Lilly Business Overview
Table 101. Eli Lilly Non-small Cell Lung Cancer Therapeutics Product
Table 102. Eli Lilly Revenue in Non-small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 103. Eli Lilly Recent Development
Table 104. Sanofi Company Details
Table 105. Sanofi Business Overview
Table 106. Sanofi Revenue in Non-small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 107. Sanofi Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Non-small Cell Lung Cancer Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Alimta Features
Figure 3. Iressa Features
Figure 4. Avastin Features
Figure 5. Tarceva Features
Figure 6. Zykadia Features
Figure 7. Tagrisso Features
Figure 8. Xalkori Features
Figure 9. Cyramza Features
Figure 10. Opdivo Features
Figure 11. Alecensa Features
Figure 12. Global Non-small Cell Lung Cancer Therapeutics Market Share by Application: 2020 VS 2027
Figure 13. Hospital Case Studies
Figure 14. Clinic Case Studies
Figure 15. Non-small Cell Lung Cancer Therapeutics Report Years Considered
Figure 16. Global Non-small Cell Lung Cancer Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 17. Global Non-small Cell Lung Cancer Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 18. Global Non-small Cell Lung Cancer Therapeutics Market Share by Regions: 2020 VS 2027
Figure 19. Global Non-small Cell Lung Cancer Therapeutics Market Share by Regions (2022-2027)
Figure 20. Global Non-small Cell Lung Cancer Therapeutics Market Share by Players in 2020
Figure 21. Global Top Non-small Cell Lung Cancer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-small Cell Lung Cancer Therapeutics as of 2020
Figure 22. The Top 10 and 5 Players Market Share by Non-small Cell Lung Cancer Therapeutics Revenue in 2020
Figure 23. Global Non-small Cell Lung Cancer Therapeutics Revenue Market Share by Type (2016-2021)
Figure 24. Global Non-small Cell Lung Cancer Therapeutics Revenue Market Share by Type (2022-2027)
Figure 25. North America Non-small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. North America Non-small Cell Lung Cancer Therapeutics Market Share by Type (2016-2027)
Figure 27. North America Non-small Cell Lung Cancer Therapeutics Market Share by Application (2016-2027)
Figure 28. North America Non-small Cell Lung Cancer Therapeutics Market Share by Country (2016-2027)
Figure 29. United States Non-small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Canada Non-small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Non-small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Europe Non-small Cell Lung Cancer Therapeutics Market Share by Type (2016-2027)
Figure 33. Europe Non-small Cell Lung Cancer Therapeutics Market Share by Application (2016-2027)
Figure 34. Europe Non-small Cell Lung Cancer Therapeutics Market Share by Country (2016-2027)
Figure 35. Germany Non-small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. France Non-small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. U.K. Non-small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Italy Non-small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Russia Non-small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Nordic Non-small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Non-small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Asia-Pacific Non-small Cell Lung Cancer Therapeutics Market Share by Type (2016-2027)
Figure 43. Asia-Pacific Non-small Cell Lung Cancer Therapeutics Market Share by Application (2016-2027)
Figure 44. Asia-Pacific Non-small Cell Lung Cancer Therapeutics Market Share by Region (2016-2027)
Figure 45. China Non-small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Japan Non-small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. South Korea Non-small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Southeast Asia Non-small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. India Non-small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Australia Non-small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Non-small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Latin America Non-small Cell Lung Cancer Therapeutics Market Share by Type (2016-2027)
Figure 53. Latin America Non-small Cell Lung Cancer Therapeutics Market Share by Application (2016-2027)
Figure 54. Latin America Non-small Cell Lung Cancer Therapeutics Market Share by Country (2016-2027)
Figure 55. Mexico Non-small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Brazil Non-small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Non-small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Middle East & Africa Non-small Cell Lung Cancer Therapeutics Market Share by Type (2016-2027)
Figure 59. Middle East & Africa Non-small Cell Lung Cancer Therapeutics Market Share by Application (2016-2027)
Figure 60. Middle East & Africa Non-small Cell Lung Cancer Therapeutics Market Share by Country (2016-2027)
Figure 61. Turkey Non-small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Saudi Arabia Non-small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. UAE Non-small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. GlaxoSmithKline Revenue Growth Rate in Non-small Cell Lung Cancer Therapeutics Business (2016-2021)
Figure 65. Novartis Revenue Growth Rate in Non-small Cell Lung Cancer Therapeutics Business (2016-2021)
Figure 66. AstraZeneca Revenue Growth Rate in Non-small Cell Lung Cancer Therapeutics Business (2016-2021)
Figure 67. Roche Revenue Growth Rate in Non-small Cell Lung Cancer Therapeutics Business (2016-2021)
Figure 68. Bristol-Myers Squibb Revenue Growth Rate in Non-small Cell Lung Cancer Therapeutics Business (2016-2021)
Figure 69. Pfizer Revenue Growth Rate in Non-small Cell Lung Cancer Therapeutics Business (2016-2021)
Figure 70. Eli Lilly Revenue Growth Rate in Non-small Cell Lung Cancer Therapeutics Business (2016-2021)
Figure 71. Sanofi Revenue Growth Rate in Non-small Cell Lung Cancer Therapeutics Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
Keyplayers in Global Non-small Cell Lung Cancer Therapeutics Market Size, Status and Forecast 2021-2027
GlaxoSmithKlineNovartis
AstraZeneca
Roche
Bristol-Myers Squibb
Pfizer
Eli Lilly
Sanofi
Request Sample
Request Discount
